Correction: Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis (PLoS ONE (2012) 7: 1 (e28305) DOI: 10.1371/journal.pone.0028305);Dissecting the autocrine and paracrine roles of the CCR2-CCL2 axis in tumor survival and angiogenesis

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Izhak, Liat ^a   Wildbaum, Gizi ^a   Jung, Steffen ^c   Stein, Avi ^b   Shaked, Yuval ^a   Karin, Nathan ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CHEMOKINE RECEPTOR CCR2; ENHANCED GREEN FLUORESCENT PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; VASCULOTROPIN; CCL2 PROTEIN, MOUSE; CCR2 PROTEIN, MOUSE; CD11B ANTIGEN; CHEMOKINE RECEPTOR; CX3CR1 PROTEIN, MOUSE; DIFFERENTIATION ANTIGEN; MONOCYTE MACROPHAGE DIFFERENTIATION ANTIGEN; MONOCYTE-MACROPHAGE DIFFERENTIATION ANTIGEN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BONE MARROW CELL; CANCER CELL; CANCER INVASION; CELL VIABILITY; CONTROLLED STUDY; CX3CR1 GENE; IMMUNOHISTOCHEMISTRY; MOUSE; NEOPLASM; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; REPORTER GENE; TUMOR GROWTH; TUMOR LOCALIZATION; ANIMAL; DISEASE COURSE; EXPERIMENTAL NEOPLASM; FEMALE; GENETICS; MACROPHAGE; MALE; METABOLISM; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PARACRINE SIGNALING; PATHOLOGY; PHYSIOLOGY; PROTEIN BINDING; SURVIVAL; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR VOLUME;

ANIMALIA; MUS;

ANIMALS; ANTIGENS, CD11B; ANTIGENS, DIFFERENTIATION; AUTOCRINE COMMUNICATION; BONE MARROW CELLS; CELL LINE, TUMOR; CHEMOKINE CCL2; DISEASE PROGRESSION; FEMALE; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; NEOVASCULARIZATION, PATHOLOGIC; PARACRINE COMMUNICATION; PROTEIN BINDING; RECEPTORS, CCR2; RECEPTORS, CHEMOKINE; SURVIVAL ANALYSIS; TUMOR BURDEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84855928936     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0195170     Document Type: Erratum

References (45)

1. Rollins BJ, (1997) Chemokines. Blood 90: 909-928.
2. Zlotnic A, Yoshei O, (2000) Chemokines: A n ew clasification system and their role in immunity. Immunity 12: 121-127.
3. Mackay CR, (2001) Chemokines: immunology's high impact factors. Nat Immunol 2: 95-101.
4. Proudfoot AE, (2002) chemokine receptors: A multifaceted therapeutic targets. Nat Rev Immunol 2: 106-115.
5. Bottazzi B, Walter S, Govoni D, Colotta F, Mantovani A, (1992) Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J Immunol 148: 1280-1285.
6. Loberg RD, Ying C, Craig M, Day LL, Sargent E, et al. (2007) Targeting CCL2 with Systemic Delivery of Neutralizing Antibodies Induces Prostate Cancer Tumor Regression In vivo. Cancer Res 67: 9417-9424.
7. Mazzucchelli L, Loetscher P, Kappeler A, Uguccioni M, Baggiolini M, et al. (1996) Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. Am J Pathol 149: 501-509.
8. Soria G, Ben-Baruch A, (2008) The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 267: 271-285.
9. Hefler L, Tempfer C, Heinze G, Mayerhofer K, Breitenecker G, et al. (1999) Monocyte chemoattractant protein-1 serum levels in ovarian cancer patients. Br J Cancer 81: 855-859.
10. Loberg RD, Day LL, Harwood J, Ying C, St John LN, et al. (2006) CCL2 is a potent regulator of prostate cancer cell migration and proliferation. Neoplasia 8: 578-586.
11. Rollins BJ, (1996) Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2: 198-204.
12. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L, (1992) The origin and function of tumor-associated macrophages. Immunol Today 13: 265-270.
13. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555.
14. Gazzaniga S, Bravo AI, Guglielmotti A, van Rooijen N, Maschi F, et al. (2007) Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol 127: 2031-2041.
15. Stamatovic SM, Keep RF, Mostarica-Stojkovic M, Andjelkovic AV, (2006) CCL2 regulates angiogenesis via activation of Ets-1 transcription factor. J Immunol 177: 2651-2661.
16. Izhak L, Wildbaum G, Uri W, Shaked Y, Alami J, et al. (2010) Predominant expression of CCL2 at the tumor site of prostate cancer patients directs a selective loss of immunological tolerance to CCL2 that could be amplified in a beneficial manner. J Immunol 184: 1092-1101.
17. Fogg DK, Sibon C, Miled C, Jung S, Aucouturier P, et al. (2006) A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311: 83-87.
18. Auffray C, Fogg DK, Narni-Mancinelli E, Senechal B, Trouillet C, et al. (2009) CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J Exp Med 206: 595-606.
19. del Rio ML, Rodriguez-Barbosa JI, Bolter J, Ballmaier M, Dittrich-Breiholz O, et al. (2008) CX3CR1+ c-kit+ bone marrow cells give rise to CD103+ and CD103- dendritic cells with distinct functional properties. J Immunol 181: 6178-6188.
20. Izhak L, Wildbaum G, Zohar Y, Anunu R, Klapper L, et al. (2009) A novel recombinant fusion protein encoding a 20-amino acid residue of the third extracellular (E3) domain of CCR2 neutralizes the biological activity of CCL2. J Immunol 183: 732-739.
21. Varol C, Landsman L, Fogg DK, Greenshtein L, Gildor B, et al. (2007) Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med 204: 171-180.
22. Gingrich JR, Barrios RJ, Foster BA, Greenberg NM, (1999) Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis 2: 70-75.
23. de Wet JR, Wood KV, DeLuca M, Helinski DR, Subramani S, (1987) Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol 7: 725-737.
24. Rubio N, Villacampa MM, Blanco J, (1998) Traffic to lymph nodes of PC-3 prostate tumor cells in nude mice visualized using the luciferase gene as a tumor cell marker. Lab Invest 78: 1315-1325.
25. Hsieh CL, Xie Z, Liu ZY, Green JE, Martin WD, et al. (2005) A luciferase transgenic mouse model: visualization of prostate development and its androgen responsiveness in live animals. Journal of molecular endocrinology 35: 293-304.
26. Green J, Goldberg R, Maor G, (2003) PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: the PTH-IGF-I axis. Kidney Int 63: 487-500.
27. Ozaki H, Hayashi H, Vinores SA, Moromizato Y, Campochiaro PA, et al. (1997) Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates. Exp Eye Res 64: 505-517.
28. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, et al. (2006) Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 313: 1785-1787.
29. Adams JY, Johnson M, Sato M, Berger F, Gambhir SS, et al. (2002) Visualization of advanced human prostate cancer lesions in living mice by a targeted gene transfer vector and optical imaging. Nat Med 8: 891-897.
30. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, et al. (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 100: 2552-2561.
31. Bot I, Guo J, Van Eck M, Van Santbrink PJ, Groot PH, et al. (2005) Lentiviral shRNA silencing of murine bone marrow cell CCR2 leads to persistent knockdown of CCR2 function in vivo. Blood 106: 1147-1153.
32. Serbina NV, Pamer EG, (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7: 311-317.
33. Muller A, Homey B, Soto H, Ge N, Catron D, et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
34. Kim SJ, Kim JS, Papadopoulos J, Wook Kim S, Maya M, et al. (2009) Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. The American journal of pathology 174: 1972-1980.
35. Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, et al. (2008) Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319: 195-198.
36. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, et al. (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
37. Shaked Y, Henke E, Roodhart JM, Mancuso P, Langenberg MH, et al. (2008) Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 14: 263-273.
38. Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, et al. (2007) Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat Biotechnol 25: 911-920.
39. Shojaei F, Ferrara N, (2008) Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. Drug Resist Updat.
40. Kerbel RS, (2008) Tumor angiogenesis. N Engl J Med 358: 2039-2049.
41. Murdoch C, Muthana M, Coffelt SB, Lewis CE, (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8: 618-631.
42. Knowles H, Leek R, Harris AL, (2004) Macrophage infiltration and angiogenesis in human malignancy. Novartis Found Symp 256: 189-200; discussion 200-184, 259-169.
43. Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, et al. (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 66: 11238-11246.
44. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, et al. (2011) CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475: 222-225.
45. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.